About Lexaria

Overview

Lexaria Bioscience Corp. evolved into its current form in 2014 upon controlling acquisition of the former company where Lexaria’s DehydraTECH™ technology originated.  Since then, Lexaria has quickly emerged as a global leader in enhancing the flavor, bouquet and gastro-intestinal delivery of edible cannabinoid consumer products while also working to expand the applicability of its technology, within and beyond the cannabinoid sector, through its out-licensing business model for cannabinoids and other bioactive molecules named in its patent portfolio (NSAIDs, nicotine, vitamins and more).  Lexaria produces industry-leading research to support its novel delivery method. None of this can happen without the talented and dedicated people who have supported Lexaria’s development and growth.

Lexaria has always maximized its resources by attracting top management and advisors and also leveraging the strongest expert consultant relationships.  Supporters have included industry leaders, research scientists, clinicians, analytical chemists, intellectual property experts, study volunteers, partnering company collaborators and, of course, the original inventors of the earliest iterations of Lexaria’s DehydraTECH™ technology.

For those of you who have shared in our journey over the years, and for new participants as well, we thank you for being a part of our story.

Advisors & Consultants

Lexaria is fortunate to be the recipient of widely varying experience and knowledge from advisors who consult with the company from time to time. These experts contribute knowledge and experience on an as-needed basis in these roles that are less formal than managers or directors. Still, we benefit from their involvement and are grateful for their presence.